Sol-gel to present at upcoming healthcare investor conferences in november 2020

Ness ziona, israel, nov. 09, 2020 (globe newswire) -- sol-gel technologies (nasdaq: slgl), (“sol-gel”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that the company will present at the following upcoming virtual investor conferences.
SLGL Ratings Summary
SLGL Quant Ranking